{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:57:26Z","timestamp":1775872646891,"version":"3.50.1"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,11]]},"DOI":"10.1093\/cid\/ciad421","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T07:15:24Z","timestamp":1689318924000},"page":"1291-1293","source":"Crossref","is-referenced-by-count":11,"title":["Polymerase Chain Reaction of Plasma and Bronchoalveolar Lavage Fluid for Diagnosing Invasive Aspergillosis"],"prefix":"10.1093","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3056-4205","authenticated-orcid":false,"given":"P Lewis","family":"White","sequence":"first","affiliation":[{"name":"Public Health Wales Mycology Reference Laboratory, University Hospital of Wales , Cardiff , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Peter","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Fungal PCR Initiative , Nijmegen , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"2023111209210077900_ciad421-B1","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad420","article-title":"Superior accuracy of Aspergillus plasma cell-free DNA PCR over serum galactomannan for the diagnosis of invasive aspergillosis","author":"Mah","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2023111209210077900_ciad421-B2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/cid\/ciad141","article-title":"Clinical impact of PCR-based Aspergillus and azole resistance detection in invasive aspergillosis. A prospective multicenter study","volume":"77","author":"Huygens","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2023111209210077900_ciad421-B3","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023111209210077900_ciad421-B4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/jac\/dkaa498","article-title":"The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis","volume":"76","author":"Cruciani","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2023111209210077900_ciad421-B5","article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people","volume":"9","author":"Cruciani","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2023111209210077900_ciad421-B6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/cid\/civ507","article-title":"Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing","volume":"61","author":"White","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2023111209210077900_ciad421-B7","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cmi.2022.02.026","article-title":"The impact of the updated EORTC\/MSG criteria on the classification of hematological patients with suspected invasive pulmonary aspergillosis","volume":"28","author":"Lamberink","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2023111209210077900_ciad421-B8","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00138-19","article-title":"Candida in the respiratory tract potentially triggers galactomannan positivity in nonhematological patients","volume":"63","author":"Aigner","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2023111209210077900_ciad421-B9","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/cid\/civ555","article-title":"Galactomannan and polymerase chain reaction-based screening for invasive aspergillosis among high-risk hematology patients: a diagnostic meta-analysis","volume":"61","author":"Arvanitis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2023111209210077900_ciad421-B10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/1040841X.2013.804033","article-title":"Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis","volume":"41","author":"Heng","year":"2015","journal-title":"Crit Rev Microbiol"},{"key":"2023111209210077900_ciad421-B11","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1093\/cid\/ciaa323","article-title":"Ibrutinib is a newly recognized host factor for the definition of probable invasive pulmonary mold disease, based on off-target effects, unrelated to its B-cell immunosuppressant activity","volume":"71","author":"Luppi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023111209210077900_ciad421-B12","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1093\/cid\/ciaa205","article-title":"Validation by real-life data of the new radiological criteria of the revised and updated consensus definition for invasive fungal diseases","volume":"71","author":"Herbrecht","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023111209210077900_ciad421-B13","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab441","article-title":"Impact of changes of the 2020 consensus definitions of invasive aspergillosis on clinical trial design: unintended consequences for prevention trials?","volume":"8","author":"Wingard","year":"2021","journal-title":"Open Forum Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciad421\/51090205\/ciad421.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/9\/1291\/53302540\/ciad421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/77\/9\/1291\/53302540\/ciad421.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T09:21:40Z","timestamp":1699780900000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/77\/9\/1291\/7224058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":13,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,7,14]]},"published-print":{"date-parts":[[2023,11,11]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciad421","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11,1]]},"published":{"date-parts":[[2023,7,14]]}}}